STAND Against Emerging Opioids Act

119 HR 3520 IH: Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act U.S. House of Representatives 2025-05-20 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 3520 IN THE HOUSE OF REPRESENTATIVES May 20, 2025 Mr. Panetta (for himself and Mr. Pfluger ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to provide for the scheduling of tianeptine as a schedule III substance, and for other purposes. 1. Short title This Act may be cited as the Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act or the STAND Against Emerging Opioids Act . 2. Scheduling of tianeptine (a) In general Section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ) is amended by adding at the end of schedule III the following: (f) Tianeptine, including its analogues, salts, isomers, and salts of isomers. . (b) Effective date The amendment made by subsection (a) shall become effective on the date that is 90 days after the date of enactment of this Act.